Global Nuclear Medicine Radioisotope Market by component, technology overview and market dynamics till forecast period

Nuclear Medicine Radioisotope

The report depicts the improvement of the business by and large Challenging and Sub consecutive industry advancement, key organizations, and also compose fragment and market application and so on, and makes an authentic Forecast for the advancement business prospects based on investigation. at long last, Nuclear Medicine Radioisotope Market investigations opportunities for interest in the business toward the end of the report.

Nuclear Medicine Radioisotope Market report presents an extensive assessment of the Nuclear Medicine Radioisotope including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies.

Nuclear Medicine Radioisotope Market Report gives strategists, advertisers and senior administration with the basic data they have to evaluate the Global Nuclear Medicine Radioisotope Market. Alongside deliberately breaking down the key small scale Market, the report likewise centres around industry-particular drivers, restrictions, openings and difficulties in the Nuclear Medicine Radioisotope market. This examination report offers top to bottom investigation of the market measure (income), piece of the overall industry, real market portions, and diverse geographic locales, gauge for the following five years, key market players, and premium industry patterns. It likewise centres around the key drivers, restrictions, openings and difficulties.

Request a Sample of this report from

The global nuclear medicine radioisotope market was valued at USD 13.9 billion in 2017, and is expected to register a CAGR of 12.3% during the forecast period of 2018-2023. North America accounted for the largest share of approximately 40% of the global market, in 2017, whereas, Asia-Pacific is anticipated to register the highest CAGR over the forecast period.

Rising SPECT and PET Applications

The field of nuclear medicine is dominated by the applications related to positron emission tomography (PET) and single-photon emission computerized tomography (SPECT). The growing interest of PET technology in cardiac and neurological disorders is expected to fuel the market’s growth. More than 60% of SPECT procedures are performed in cardiology. In addition, orthopedics, oncology, and infection imaging are emerging as areas that can benefit from the same. Applications have been further increasing, through the inclusion of advancements in computed tomography (CT), making nuclear medicine the right choice for disease diagnosis. In addition, factors, such as rising incidences of cardiac and cancer cases, along with the rising awareness among the public, drive the nuclear medicine market.

High Capital Investments Involved

One of the major hindrance for the nuclear medicine radioisotope market is the high capital investments required for the generation of radionuclide. Cyclotron initial investment is very high, which is followed by renovation and installation. Further, annual operating costs are involved. With high investment, the cost of imaging and treatment becomes a factor of high expenditure, especially in developing markets. These factors, and unclear regulatory guidelines, varied reimbursement policies, and short half-life of radiopharmaceuticals restrict the growth of the market studied.

North America to Dominate the Market

The global nuclear medicine radioisotope market has been segmented by type of radioisotope, application in different indications, and geography. Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.
North America dominated the nuclear medicine radioisotope market, with a share of 40%, in 2017. The factors, such as well-established healthcare facilities, growing geriatric population, rising awareness among people for nuclear medicine treatments and diagnosis, contribute to the growth of the regional market. Moreover, Asia-Pacific is estimated to register the highest CAGR during the forecast period.

Key Developments in the Market

• December 2017: Caris Life Sciences identified a new mechanism for the treatment of non-Hodgkin lymphoma (NHL), using a single-stranded DNA aptamer, C10.36, specifically binding to heterogeneous nuclear ribonucleoprotein U (hnRNP U).
• October 2017: Siemens Healthcare introduced biograph vision PET/CT system, a software platform at the 30th Annual Congress of the European Association of Nuclear Medicine (EANM), to provide a new level of precision in PET/CT imaging.


Reasons to Purchase This Report

• Analysis of the global nuclear medicine radioisotope market, with region-specific assessments and competition analysis, on global and regional scales.
• Analyzing various perspectives of the industry with the help of Porter’s five forces analysis.
• The treatment type that is expected to dominate the market.
• Regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).

Customization Of The Report

• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Access Nuclear Medicine Radioisotope Market Report at: –    

Nuclear Medicine Radioisotope Market Forecast 2018-2023

The Nuclear Medicine Radioisotope industry research report analyses the supply, sales, production, and market status comprehensively. Production market shares and sales market shares are analysed along with the study of capacity, production, sales, and revenue. Several other factors such as import, export, gross margin, price, cost, and consumption are also analysed under the section Analysis of Nuclear Medicine Radioisotope production, supply, sales and market status.

Price of Report (Single User Licence): – $4250

Purchase this Report@: 


Share this post